Physician profile
Joseph D Becker
NPI 1780613158
$638.56
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $111.79 | 2019-2020 | |
| Adlon Therapeutics L.P. | $85.18 | 2019-2020 | |
| Neos Therapeutics, LP | $69.58 | 2019 | |
| Ironshore Pharmaceuticals INC. | $49.04 | 2019-2020 | |
| Glaxosmithkline, LLC. | $43.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.60 | 2019-2020 | |
| Pfizer INC. | $38.75 | 2019 | |
| Alexion Pharmaceuticals, INC. | $38.11 | 2019 | |
| Kaleo, INC. | $34.98 | 2019 | |
| Vertical Pharmaceuticals, LLC | $30.37 | 2019 | |
| Sanofi Pasteur INC. | $27.09 | 2020 | |
| Shire North American Group INC | $23.45 | 2019 | |
| Mission Pharmacal Company | $17.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.89 | 2019 | |
| Phadia US INC. | $12.62 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.